Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013637 · ClinicalTrials.gov registry record

Lead Exposure, Genetics, and Osteoporosis Epidemiology

A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Completed
Registry status
650
Enrollment target

NCT00013637: Completed study, sponsored by National Institute of Environmental Health Sciences (NIEHS).

NCT00013637 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 650 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013637 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).

COMPLETED
Registry status
650 participants
Enrollment target

Study Summary

This study's primary objective is to assess the effects of environmental lead exposures and genetic risk factors on the development of osteoporosis in middle-aged women.

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 1998-09
Est. Completion 2003-08

What the finished NCT00013637 record still lists

NCT00013637 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00013637 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00013637 about?

NCT00013637 is a clinical study titled "Lead Exposure, Genetics, and Osteoporosis Epidemiology". This study's primary objective is to assess the effects of environmental lead exposures and genetic risk factors on the development of osteoporosis in middle-aged women.

What is the current status of trial NCT00013637?

This trial is currently completed. The enrollment target is 650 participants. The study started on 1998-09. Estimated completion is 2003-08.

Who is sponsoring clinical trial NCT00013637?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02934477 · 650 participants

    Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

  • NCT04579120 · 650 participants

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

  • NCT04875702 · 650 participants · Phase 4

    Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

  • NCT05046600 · 650 participants

    Registry of Arthrex Hand and Wrist Products

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00013637, the US trial registry maintained by the National Library of Medicine. NCT00013637 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.